CT may be used less often in diagnosing TBI with early measurement of glial fibrillary acidic protein and its breakdown products (GFAP-BDP).
Early measurement of glial fibrillary acidic protein and its breakdown products (GFAP-BDP) can contribute to diagnosis and triage of patients with traumatic brain injury (TBI), reducing the use of CT imaging, according to a study published in the Journal of Neurotrauma.
Researchers from the United States, the Netherlands, Belgium, and the United Kingdom performed a multi-center, prospective, cohort study to evaluate the use of GFAP-BDP in the diagnosis of intracranial injury in patients with a positive clinical screen for head injury.
The researchers analyzed blood GFAP-BDP levels in 215 patients, ranging in age from 16 to 93 (mean age, 42.1±18), who presented to an emergency department within 24 hours of a head injury and had a positive clinical screen for acute TBI. Eight-three percent suffered mild TBI, 4% moderate, and 12% severe. Other findings:
• Approximately 73% of patients were male
• 70% of patients had a documented loss of consciousness (LOC)
• 38% of patients had documented post-traumatic amnesia (PTA)
• Median Injury Severity Score (ISS) was 10 (IQR, 17), with 36% suffering significant polytrauma (ISS, ≥16)
The GFAP-BDP proved to have good predictive ability (AUC=0.87) and significant discrimination of injury severity, the researchers found. The use of GFAP-BDP yielded a net benefit above clinical screening alone and a net reduction in unnecessary scans by 12% to 30%: “GFAP-BDP level was the most accurate predictor of the presence or absence of intracranial injury detected by radiographic imaging (accuracy, 81%), as compared with accepted clinical predictors of intracranial injury (age, 65%; GCS, 62%; LOC and/or PTA, 54%; pupillary status, 52%).”
The researchers found that the accuracy of GFAP-BDP for injury prediction was superior to the ACEP/CDC recommended criteria for neuroimaging in TBI (81% versus 65%, respectively). “Used in conjunction with other clinical information, rapid measurement of GFAP-BDP is useful in establishing or excluding the diagnosis of radiographically apparent intracranial injury throughout the spectrum of TBI. As an adjunct to current screening practices, GFAP-BDP may help avoid unnecessary CT scans without sacrificing sensitivity.”
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.